🌍·14h agoResearch
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial
Publisher
N
Nature Cancer
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: Nature Cancer
Scope: Research
Related coverage
More related coverage
Manchester University NHS Foundation Trust·4h ago
Come on England! Fans urged to register their organ donation decision during the World Cup
Hospital Clínic de Barcelona·5h ago
Dengue Vaccine Shows Favourable Safety Profile in Travellers from Non-Endemic Regions
UNMC·7h ago
‘What if that could be me?’
Hospital Clínic de Barcelona·7h ago